Back

Reata Pharmaceuticals Quote, Financials, Valuation and Earnings

Your Chance To Invest In The Green Energy Revolution!

Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!

Buy

RETA
Reata Pharmaceuticals

Last Price:

42.84

Seasonality Move:

-9.52%

7 Day Trial

ALL ACCESS PASS

$ 7

New Year, New Trades, Try A.I. Today

Learn to forecast trends with up to 87.4% proven accuracy -> Register Here

Reata Pharmaceuticals Price Quote

$42.84

+1.98 (+4.85%)

(Updated: January 27, 2023 at 12:30 PM ET)

Reata Pharmaceuticals Key Stats

Buy

Reata Pharmaceuticals (RETA) is a Buy

Day range:

$38.97 - $42.49

52-week range:

$18.47 - $46.90

Dividend yield:

P/E ratio:

0.00

P/S ratio:

473.22

P/B ratio:

331.71%

Volume:

Avg. volume:

556.4K

1-year change:

54.6%

Market cap:

$1.5B

Revenue:

$11.5M

EPS:

$-8.56

How Much Does Reata Pharmaceuticals Make?

How Much Are Reata Pharmaceuticals's Sales Annually?
RETA Revenues are $11.5M
How Much Profit Does Reata Pharmaceuticals's Make A Year?
RETA net income is -$297.4M

Is Reata Pharmaceuticals Growing As A Company?

What Is Reata Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.93%
What Is Reata Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Reata Pharmaceuticals Stock Price Performance

Did Reata Pharmaceuticals Stock Go Up Last Month?
Reata Pharmaceuticals share price went up by 13.5% last month
Did RETA's Share Price Rise Over The Last Year?
RETA share price rose by 54.6% over the past 1 year

What Is Reata Pharmaceuticals 52-Week High & Low?

What Is Reata Pharmaceuticals’s 52-Week High Share Price?
Reata Pharmaceuticals has traded as high as $46.90 over the past 52 weeks
What Is Reata Pharmaceuticals’s 52-Week Low Share Price?
Reata Pharmaceuticals has traded as low as $18.47 over the past 52 weeks

Reata Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Reata Pharmaceuticals?

How Much Debt Does Reata Pharmaceuticals Have?
Total long term debt quarterly is $0
How Much Cash Does Reata Pharmaceuticals Have?
Cash and short term investments quarterly total is $435.9M
What Is Reata Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.12

Is Reata Pharmaceuticals Cash Flow Positive?

What Is RETA Cash Flow From Operations?
Cash flow from operations (TTM) is -$276.8M
What Is Reata Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.3M
What Is Reata Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$405.9M

Reata Pharmaceuticals Return On Invested Capital

Is Management Doing A Good Job?
RETA return on invested capital is -242.48%
What Is Reata Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -46.37%
What Is RETA Return On Equity?
ROE is a measure of profitability and is -242.48%

Reata Pharmaceuticals Earnings Date & Stock Price

What Is Reata Pharmaceuticals's Stock Price Today?
A single share of RETA can be purchased today for 40.86
What Is Reata Pharmaceuticals’s Stock Symbol?
Reata Pharmaceuticals trades on the nasdaq under the ticker symbol: RETA
When Is Reata Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Reata Pharmaceuticals is scheduled on February 28, 2023
When Is RETA's next ex-dividend date?
Reata Pharmaceuticals's next ex-dividend date is January 27, 2023
How To Buy Reata Pharmaceuticals Stock?
You can buy Reata Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Reata Pharmaceuticals Competitors

Who Are Reata Pharmaceuticals's Competitors?
Below is a list of companies who compete with Reata Pharmaceuticals or are related in some way:
- Heron Therapeutics Inc (HRTX)
- iBio Inc (IBIO)
- Karuna Therapeutics Inc (KRTX)
- NovaBay Pharmaceuticals Inc (NBY)
- Palatin Technologies Inc (PTN)

Reata Pharmaceuticals Dividend Yield